Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Hormone-Dependent breast cancer"'
Autor:
I. V. Kolyadina
Publikováno v:
Опухоли женской репродуктивной системы, Vol 20, Iss 1, Pp 89-103 (2024)
This review presents the evolution of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer, describes late relapse phenomenon, provides clinical rationale for escalation of treatment, analyzes the key stages of the metas
Externí odkaz:
https://doaj.org/article/9e0dc10a36ac41af969d515ba1adb06b
Autor:
L. K. Ovchinnikova, A. D. Belko
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 87-91 (2019)
Breast cancer (BC) ranks first in the morbidity pattern among women in Russia. Adjuvant endocrinotherapy is an important step in the complex treatment of premenopausal patients with hormone-positive early breast cancer. The drug ovarian suppression w
Externí odkaz:
https://doaj.org/article/51b60b60735c4f96a8bf532bbf41c185
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 146, Iss 9-10, Pp 524-529 (2018)
Introduction/Objective. Activation of insulin-like growth factor receptor (IGF-1R) results in cell transition from growth phase to synthesis phase of cell cycle. Breast cancer is categorized into prognostic and therapeutic subtypes based upon hormone
Externí odkaz:
https://doaj.org/article/b519e00920db4c70b84c5d81776d0c36
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 28-30 (2018)
Treatment of choice of metastatic hormone-dependent breast cancer regardless of age is hormone therapy (HT) even with visceral metastases. Now we have a new class of drugs called inhibitors of cyclin-dependent kinases 4/6, which significantly increas
Externí odkaz:
https://doaj.org/article/13b79c9efaba4013bdb873623360288f
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 158-160 (2018)
According with the present-day ideas, sequential lines of hormone therapy including those in patients with visceral metastases and multiple lesions form the basis of the treatment of HER2-negative metastatic hormone-dependent breast cancer. These mea
Externí odkaz:
https://doaj.org/article/5ff8b028fe6f43a291a5693e53af21f5
Autor:
L. A. Ashrafyan, N. A. Babaeva, I. B. Antonova, O. A. Ovchinnikova, O. I. Aleshikova, T. A. Motskobili, I. N. Kuznetsov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 11, Iss 3, Pp 22-29 (2015)
Background. A clear relationship is now found between the activity of estrogen metabolites and the development of tumors in estrogen-dependent tissues. Many international and Russian studies could identify a number of compounds involved in the regula
Externí odkaz:
https://doaj.org/article/eab44fe886e64c728cb6d402c98669d1
Autor:
Pavličić, Petrik
U hormonski ovisnom tipu ranog raka dojke visoko preživljenje je posljedica vrlo učinkovitog endokrinog liječenja. Međutim, dugotrajno AEL koje obuhvaća aromatazne inhibitore (anastrozol, letrozol i ekesemestan) i tamoksifen dovodi do brojnih nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::89e791f0e378ac47fc3283a5875f9841
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:2511
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:2511
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sikavica, Lorena
Gotovo tri četvrtine malignih karcinoma dojke čine upravo ER+ tumori koji primarno pogađaju postmenopauzalne žene. Po završetku lokalne terapije i kemoterapije - adjuvantno, indicirana je primjena ciljane endokrine (antihormonske) terapije. AET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9c91bc795921284fbee2025b2e1e719f
https://www.bib.irb.hr/1269849
https://www.bib.irb.hr/1269849